Specialty Chemicals

The company posted a consolidated revenue from operations at Rs 540 crore, higher by 59 percent on year, and a net profit of Rs 135.8 crore, up 65 percent on year. Revenue from the CRDMO business grew up 70 percent on year. Anthem's EBITDA rose by 52.7 percent to Rs 214.3 crore.

In FY25, we will need FII flows to support the market: Saurabh Mukherjea

The founder of the portfolio management service weighs in on the good and the ugly that the Indian market has seen and has emerged stronger from. He also has a word of caution about the bad that could be around the corner later this year.

PCBL zooms over 10% to climb fresh record high; multibagger stock up 200% in a year

Shares of PCBL surged to a record high after the company highlighted significant growth opportunities amid a favorable global scenario for India's rubber black industry.

Piramal fund in talks to acquire ICICI Ventures-backed speciality chemicals maker Anthea Aromatics for $132 million

ICICI Ventures invested Rs 120 crore in the company in 2016 to acquire a minority stake.

Deepak Nitrite stock surges 7% to hit fresh high on double upgrade from Morgan Stanley

Recognising industry-leading metrics and top-quartile returns, Morgan Stanley anticipates Deepak Nitrite to outperform further as new investments yield results and earnings improve.

Short Call | What's cooking for specialty chemicals? Tata Tech on a roll, NMDC falls short, JSW Energy QIP cheers bulls

Things are better in the hydro fluro carbon (HFC) space in terms of pricing, but volumes are yet to pick up

SRF: Last leg of inventory rationalisation provides an opportunity

The management sees a sharp sequential recovery as channel inventory and pricing situation are stabilising. Further, new capacities for varied product categories are expected to contribute in the coming months.

Cloudy outlook for Indian chemical firms as cheap Chinese imports flood market

Major domestic players such as Balaji Amines, Aarti Industries and Alkyl Amines reported a 20-50 percent decline in quarterly profit from the year-ago period

'Cautious' on chemical sector, Kotak Institutional Equities’ analysts downgrade two stocks

They believe that the factors that are driving the recent rally in the stocks may be short term

Specialty chemicals companies to ride high on China+1, EU production slump

Sensing the opportunity, Indian chemical players have opened the capex tap, pumping in Rs 9,100 crore in FY23

Growth pangs to continue for specialty chemicals, says Nuvama Institutional Equities

Weakening demand, softening raw material prices and inventory liquidation are hurting India's specialty chemical players

Expect EBITDA margin to sustain at 25-30% in FY24, says Meghmani Finechem CMD Maulik Patel

Though the China+1 theme has lent greater focus on Indian manufacturing, Patel feels India has quite a distance to cover to catch up with China in this sphere.

Camlin Fine Sciences’ earnings could get a boost with Infinity Holdings, AVH as new co-promoters

The PE players’ diverse strengths can benefit the company in its future strategies, and lend strength to its standing as a key global supplier of specialty chemicals, food chemicals and preservatives, says Axis Securities

Channel checks by ICICI Securities reflect mixed price, volume trends for Specialty Chemcials cos in January

ICICI Securities has a "buy" rating on Gujarat Fluorochemicals, Archean Chemical, Tatva Chintan, EPL, Chemplast Sanmar, PCBL in the specialty chemicals basket, along with a "hold" call for industry leader SRF.

Know your stock: Will Privi Specialty’s rollercoaster ride end now?

The stock has plunged over the last year and gained significantly over the last month.

Navin Fluorine: Pick-up in demand from pharma innovators a key watch

Valuation is quite rich and investors should wait for a better opportunity to accumulate this stock

Navin Fluorine: Diversification away from agrochemicals to set it apart

Navin Fluorine is increasingly looking towards fluoro applications in performance materials. Among the new product platforms to watch out for would be those of fluoropyridine

SRF: Capex intensity in free flow

Among the recent announcements, what got our attention is more than 50 percent expansion for the belting fabrics capacity to cater to demand as infrastructure spend revives.

Clean Science and Technology: Capacity additions to help gain market share

Clean Science and Technology’s progress in capacity addition and product diversification bode well for the company’s future growth

Specialty chemicals: Companies increase capex on demand surge from domestic and global players

Despite input-cost risks, analysts and companies are optimistic about revenues next fiscal, though there is some concern about the margins

Specialty Chemicals Q4 Preview | Revenue growth seen strong on firm demand

Margins of specialty chemicals companies will see pressure on a year-on-year basis given the more than 36% jump in crude oil in the March quarter.

Indian chemical industry in a sweet spot as Europe struggles

The ongoing energy crisis which disproportionately impacts Europe can further help Indian firms reach out to export markets of European chemical companies

Inflation scare: Is early Fed rate hike in the offing before March meet?

Fed Funds futures are pricing in about five rate hikes of 25 basis points each in 2022 and a few FOMC members are getting vocal about the need for a 50 bps rate hike in the 15-16th March meet, to start with

Chemplast Sanmar does well post IPO, reports 48% jump in consolidated PAT

It reported a consolidated PAT of Rs.236.86 crore on revenue of Rs.1,431.68 crore for the quarter ended December, 2021.

SRF: Inflation can impact capex payback period

For FY22, SRF's capex allocation stands at Rs 1,500-1,800 crore. The capex spent so far is nearly Rs 600 crore, which is expected to go up in H2